Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by Sir_Holleron Apr 30, 2015 12:40pm

284 Views

Post# 23681049

RE:Extremely positive conference call

"Aggrastat capturing market share from both competitors and also challenging Angiomax which has over 1 billion sales."

AGGRASTAR has a short infusion time and costs a small fraction:

"Typical hospital savings: $100,000 - $1,500,000 / year"
Pg. 12 https://www.medicure.com/upload/pdfs/investor_presentation.pdf

Bullboard Posts

Rick Rule’s election insights: Gold, USD, and Canadian gas